Cernostics
Pittsburgh, PA
Cernostics is a life science company developing new molecular diagnostic tests for the fight against cancer. Most current diagnostic approaches offer a limited view of cancer because they fail to evaluate the tumor as a system composed of multiple cell types, not merely tumor cells. Its patent-protected technology platform, TissueCypher, uniquely analyzes whole slide digital images with multiplexed fluorescence, providing greater information and accuracy than traditional subjective tissue diagnostics.
cernostics.comCompany Details
Founded
- 2008
Employees
- Between 10 - 50 employees
Raised
- $21,260,848
Headquarters Location
- Pittsburgh, PA
Public
- No
Acquired
- Yes
CEO
- Mike Hoerres
Founders
- Rebecca Critchley-Thorne
Company Collections
These are collections Cernostics is a part of. Click on the collection name to view similar companies.